Loading…

Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens

Abstract Membrane vesicles (MVs), discrete nano-structures produced from the outer membrane of Gram-negative bacteria such as Salmonella enterica Typhimurium ( S. Typhimurium), strongly activate dendritic cells (DCs), contain major antigens (Ags) recognized by Salmonella -specific B-cells and CD4+ T...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2015-09, Vol.33 (38), p.5012-5019
Main Authors: Laughlin, Richard C, Mickum, Megan, Rowin, Kristina, Adams, L. Garry, Alaniz, Robert C
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243
cites cdi_FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243
container_end_page 5019
container_issue 38
container_start_page 5012
container_title Vaccine
container_volume 33
creator Laughlin, Richard C
Mickum, Megan
Rowin, Kristina
Adams, L. Garry
Alaniz, Robert C
description Abstract Membrane vesicles (MVs), discrete nano-structures produced from the outer membrane of Gram-negative bacteria such as Salmonella enterica Typhimurium ( S. Typhimurium), strongly activate dendritic cells (DCs), contain major antigens (Ags) recognized by Salmonella -specific B-cells and CD4+ T-cells, and provide protection against S. Typhimurium challenge in a mouse model. With this in mind, we hypothesized that alterations to the gene expression profile of bacteria will be reflected in the immunologic response to MVs. To test this, we assessed the ability of MVs from wild-type (WT) S. Typhimurium or a strain with a phenotype mimicking the intracellular-phase of S. Typhimurium (PhoPc ) to activate dendritic cells and initiate a strong inflammatory response. MVs, isolated from wild-type and PhoPc S. Typhimurium (WT MVs andPhoPc MVs, respectively) had pro-inflammatory properties consistent with the parental bacterial strains:PhoPc MVs were less stimulatory for DC activation in vitro and were impaired for subsequent inflammatory responses compared toWT MVs. Interestingly, the reduced pro-inflammatory properties ofPhoPc MVs did not completely rely on signals through TLR4, the receptor for LPS. Nonetheless, bothWT MVs andPhoPc MVs contained abundant immunogenic antigens capable of being recognized by memory-immune CD4+ T-cells from mice previously infected with S. Typhimurium. Furthermore, we analyzed a suite of pathogenic Gram-negative bacteria and their purified MVs for their ability to activate DCs and stimulate inflammation in a manner consistent with the known inflammatory properties of the parental strains, as shown for S. Typhimurium. Finally, analysis of the potential vaccine utility of S. Typhimurium MVs revealed their capacity to encapsulate an exogenous model antigen and stimulate antigen-specific CD4+ and CD8+ T-cell responses. Taken together, our results demonstrate the dependence of bacterial cell gene expression for MV immunogenicity and subsequent in vitro immunologic response, as well as their potential utility as a vaccine platform.
doi_str_mv 10.1016/j.vaccine.2015.05.014
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1717495437</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X15006350</els_id><sourcerecordid>3798264231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243</originalsourceid><addsrcrecordid>eNqNkk9r3DAQxUVpaTZ_PkKLoZdcvB1JlmxfWkJo0kKgh7SQU4QsjxNtLWkr2Qv59pXZbQu5tDAgGH56eqM3hLyhsKZA5fvNeqeNsR7XDKhYQy5avSAr2tS8ZII2L8kKmKzKisLdETlOaQMAgtP2NTliEjLN2YrcX4wTRuyLx5Cmwjo3eywipm3wCVMxhcKh66LO3R0ma8bcHGJwxa0eXfA4jrrQvi-uo3alxwc92R0WWz09hgf06ZS8GvSY8OxwnpDvV5--XX4ub75ef7m8uCmNEHQqKw201ig6bFH0HQ5c8F6Aboe6NQ00sjFN1bWi5azTYCSXsmYghnZomEFW8RNyvtfdxvBzxjQpZ5NZ3HkMc1K0pnXViorX_4OCFEJwltF3z9BNmKPPg2QK2mydUZopsadMDClFHNQ2Wqfjk6KglqzURh2yUktWCnLRxfPbg_rcOez_3PodTgY-7gHMP7ezGFUyFr3B3kY0k-qD_ecTH54pmNF6a_T4A58w_Z1GJaZA3S4Ls-wLFQCSC-C_AJQyu-o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1709551211</pqid></control><display><type>article</type><title>Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens</title><source>ScienceDirect Journals</source><creator>Laughlin, Richard C ; Mickum, Megan ; Rowin, Kristina ; Adams, L. Garry ; Alaniz, Robert C</creator><creatorcontrib>Laughlin, Richard C ; Mickum, Megan ; Rowin, Kristina ; Adams, L. Garry ; Alaniz, Robert C</creatorcontrib><description>Abstract Membrane vesicles (MVs), discrete nano-structures produced from the outer membrane of Gram-negative bacteria such as Salmonella enterica Typhimurium ( S. Typhimurium), strongly activate dendritic cells (DCs), contain major antigens (Ags) recognized by Salmonella -specific B-cells and CD4+ T-cells, and provide protection against S. Typhimurium challenge in a mouse model. With this in mind, we hypothesized that alterations to the gene expression profile of bacteria will be reflected in the immunologic response to MVs. To test this, we assessed the ability of MVs from wild-type (WT) S. Typhimurium or a strain with a phenotype mimicking the intracellular-phase of S. Typhimurium (PhoPc ) to activate dendritic cells and initiate a strong inflammatory response. MVs, isolated from wild-type and PhoPc S. Typhimurium (WT MVs andPhoPc MVs, respectively) had pro-inflammatory properties consistent with the parental bacterial strains:PhoPc MVs were less stimulatory for DC activation in vitro and were impaired for subsequent inflammatory responses compared toWT MVs. Interestingly, the reduced pro-inflammatory properties ofPhoPc MVs did not completely rely on signals through TLR4, the receptor for LPS. Nonetheless, bothWT MVs andPhoPc MVs contained abundant immunogenic antigens capable of being recognized by memory-immune CD4+ T-cells from mice previously infected with S. Typhimurium. Furthermore, we analyzed a suite of pathogenic Gram-negative bacteria and their purified MVs for their ability to activate DCs and stimulate inflammation in a manner consistent with the known inflammatory properties of the parental strains, as shown for S. Typhimurium. Finally, analysis of the potential vaccine utility of S. Typhimurium MVs revealed their capacity to encapsulate an exogenous model antigen and stimulate antigen-specific CD4+ and CD8+ T-cell responses. Taken together, our results demonstrate the dependence of bacterial cell gene expression for MV immunogenicity and subsequent in vitro immunologic response, as well as their potential utility as a vaccine platform.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2015.05.014</identifier><identifier>PMID: 26001432</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Allergy and Immunology ; Animals ; Bacteria ; Bacterial Vaccines - immunology ; Bacteriology ; CD4-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - immunology ; Cell-Derived Microparticles - immunology ; Colleges &amp; universities ; Conflicts of interest ; Dendritic cell ; Dendritic Cells - immunology ; Female ; Gene expression ; Genetic engineering ; Gram-negative bacteria ; Immunity, Innate ; Immunogenicity ; Infections ; Inflammation ; Laboratories ; Membrane vesicle ; Mice, Inbred C3H ; Molecular weight ; Peptides ; Salmonella ; Salmonella enterica typhimurium ; Salmonella typhimurium ; Salmonella typhimurium - immunology ; Vaccine platform ; Vaccines</subject><ispartof>Vaccine, 2015-09, Vol.33 (38), p.5012-5019</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Sep 11, 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243</citedby><cites>FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26001432$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Laughlin, Richard C</creatorcontrib><creatorcontrib>Mickum, Megan</creatorcontrib><creatorcontrib>Rowin, Kristina</creatorcontrib><creatorcontrib>Adams, L. Garry</creatorcontrib><creatorcontrib>Alaniz, Robert C</creatorcontrib><title>Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract Membrane vesicles (MVs), discrete nano-structures produced from the outer membrane of Gram-negative bacteria such as Salmonella enterica Typhimurium ( S. Typhimurium), strongly activate dendritic cells (DCs), contain major antigens (Ags) recognized by Salmonella -specific B-cells and CD4+ T-cells, and provide protection against S. Typhimurium challenge in a mouse model. With this in mind, we hypothesized that alterations to the gene expression profile of bacteria will be reflected in the immunologic response to MVs. To test this, we assessed the ability of MVs from wild-type (WT) S. Typhimurium or a strain with a phenotype mimicking the intracellular-phase of S. Typhimurium (PhoPc ) to activate dendritic cells and initiate a strong inflammatory response. MVs, isolated from wild-type and PhoPc S. Typhimurium (WT MVs andPhoPc MVs, respectively) had pro-inflammatory properties consistent with the parental bacterial strains:PhoPc MVs were less stimulatory for DC activation in vitro and were impaired for subsequent inflammatory responses compared toWT MVs. Interestingly, the reduced pro-inflammatory properties ofPhoPc MVs did not completely rely on signals through TLR4, the receptor for LPS. Nonetheless, bothWT MVs andPhoPc MVs contained abundant immunogenic antigens capable of being recognized by memory-immune CD4+ T-cells from mice previously infected with S. Typhimurium. Furthermore, we analyzed a suite of pathogenic Gram-negative bacteria and their purified MVs for their ability to activate DCs and stimulate inflammation in a manner consistent with the known inflammatory properties of the parental strains, as shown for S. Typhimurium. Finally, analysis of the potential vaccine utility of S. Typhimurium MVs revealed their capacity to encapsulate an exogenous model antigen and stimulate antigen-specific CD4+ and CD8+ T-cell responses. Taken together, our results demonstrate the dependence of bacterial cell gene expression for MV immunogenicity and subsequent in vitro immunologic response, as well as their potential utility as a vaccine platform.</description><subject>Allergy and Immunology</subject><subject>Animals</subject><subject>Bacteria</subject><subject>Bacterial Vaccines - immunology</subject><subject>Bacteriology</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Cell-Derived Microparticles - immunology</subject><subject>Colleges &amp; universities</subject><subject>Conflicts of interest</subject><subject>Dendritic cell</subject><subject>Dendritic Cells - immunology</subject><subject>Female</subject><subject>Gene expression</subject><subject>Genetic engineering</subject><subject>Gram-negative bacteria</subject><subject>Immunity, Innate</subject><subject>Immunogenicity</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Laboratories</subject><subject>Membrane vesicle</subject><subject>Mice, Inbred C3H</subject><subject>Molecular weight</subject><subject>Peptides</subject><subject>Salmonella</subject><subject>Salmonella enterica typhimurium</subject><subject>Salmonella typhimurium</subject><subject>Salmonella typhimurium - immunology</subject><subject>Vaccine platform</subject><subject>Vaccines</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNkk9r3DAQxUVpaTZ_PkKLoZdcvB1JlmxfWkJo0kKgh7SQU4QsjxNtLWkr2Qv59pXZbQu5tDAgGH56eqM3hLyhsKZA5fvNeqeNsR7XDKhYQy5avSAr2tS8ZII2L8kKmKzKisLdETlOaQMAgtP2NTliEjLN2YrcX4wTRuyLx5Cmwjo3eywipm3wCVMxhcKh66LO3R0ma8bcHGJwxa0eXfA4jrrQvi-uo3alxwc92R0WWz09hgf06ZS8GvSY8OxwnpDvV5--XX4ub75ef7m8uCmNEHQqKw201ig6bFH0HQ5c8F6Aboe6NQ00sjFN1bWi5azTYCSXsmYghnZomEFW8RNyvtfdxvBzxjQpZ5NZ3HkMc1K0pnXViorX_4OCFEJwltF3z9BNmKPPg2QK2mydUZopsadMDClFHNQ2Wqfjk6KglqzURh2yUktWCnLRxfPbg_rcOez_3PodTgY-7gHMP7ezGFUyFr3B3kY0k-qD_ecTH54pmNF6a_T4A58w_Z1GJaZA3S4Ls-wLFQCSC-C_AJQyu-o</recordid><startdate>20150911</startdate><enddate>20150911</enddate><creator>Laughlin, Richard C</creator><creator>Mickum, Megan</creator><creator>Rowin, Kristina</creator><creator>Adams, L. Garry</creator><creator>Alaniz, Robert C</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20150911</creationdate><title>Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens</title><author>Laughlin, Richard C ; Mickum, Megan ; Rowin, Kristina ; Adams, L. Garry ; Alaniz, Robert C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Allergy and Immunology</topic><topic>Animals</topic><topic>Bacteria</topic><topic>Bacterial Vaccines - immunology</topic><topic>Bacteriology</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Cell-Derived Microparticles - immunology</topic><topic>Colleges &amp; universities</topic><topic>Conflicts of interest</topic><topic>Dendritic cell</topic><topic>Dendritic Cells - immunology</topic><topic>Female</topic><topic>Gene expression</topic><topic>Genetic engineering</topic><topic>Gram-negative bacteria</topic><topic>Immunity, Innate</topic><topic>Immunogenicity</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Laboratories</topic><topic>Membrane vesicle</topic><topic>Mice, Inbred C3H</topic><topic>Molecular weight</topic><topic>Peptides</topic><topic>Salmonella</topic><topic>Salmonella enterica typhimurium</topic><topic>Salmonella typhimurium</topic><topic>Salmonella typhimurium - immunology</topic><topic>Vaccine platform</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laughlin, Richard C</creatorcontrib><creatorcontrib>Mickum, Megan</creatorcontrib><creatorcontrib>Rowin, Kristina</creatorcontrib><creatorcontrib>Adams, L. Garry</creatorcontrib><creatorcontrib>Alaniz, Robert C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laughlin, Richard C</au><au>Mickum, Megan</au><au>Rowin, Kristina</au><au>Adams, L. Garry</au><au>Alaniz, Robert C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2015-09-11</date><risdate>2015</risdate><volume>33</volume><issue>38</issue><spage>5012</spage><epage>5019</epage><pages>5012-5019</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Abstract Membrane vesicles (MVs), discrete nano-structures produced from the outer membrane of Gram-negative bacteria such as Salmonella enterica Typhimurium ( S. Typhimurium), strongly activate dendritic cells (DCs), contain major antigens (Ags) recognized by Salmonella -specific B-cells and CD4+ T-cells, and provide protection against S. Typhimurium challenge in a mouse model. With this in mind, we hypothesized that alterations to the gene expression profile of bacteria will be reflected in the immunologic response to MVs. To test this, we assessed the ability of MVs from wild-type (WT) S. Typhimurium or a strain with a phenotype mimicking the intracellular-phase of S. Typhimurium (PhoPc ) to activate dendritic cells and initiate a strong inflammatory response. MVs, isolated from wild-type and PhoPc S. Typhimurium (WT MVs andPhoPc MVs, respectively) had pro-inflammatory properties consistent with the parental bacterial strains:PhoPc MVs were less stimulatory for DC activation in vitro and were impaired for subsequent inflammatory responses compared toWT MVs. Interestingly, the reduced pro-inflammatory properties ofPhoPc MVs did not completely rely on signals through TLR4, the receptor for LPS. Nonetheless, bothWT MVs andPhoPc MVs contained abundant immunogenic antigens capable of being recognized by memory-immune CD4+ T-cells from mice previously infected with S. Typhimurium. Furthermore, we analyzed a suite of pathogenic Gram-negative bacteria and their purified MVs for their ability to activate DCs and stimulate inflammation in a manner consistent with the known inflammatory properties of the parental strains, as shown for S. Typhimurium. Finally, analysis of the potential vaccine utility of S. Typhimurium MVs revealed their capacity to encapsulate an exogenous model antigen and stimulate antigen-specific CD4+ and CD8+ T-cell responses. Taken together, our results demonstrate the dependence of bacterial cell gene expression for MV immunogenicity and subsequent in vitro immunologic response, as well as their potential utility as a vaccine platform.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>26001432</pmid><doi>10.1016/j.vaccine.2015.05.014</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2015-09, Vol.33 (38), p.5012-5019
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_1717495437
source ScienceDirect Journals
subjects Allergy and Immunology
Animals
Bacteria
Bacterial Vaccines - immunology
Bacteriology
CD4-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - immunology
Cell-Derived Microparticles - immunology
Colleges & universities
Conflicts of interest
Dendritic cell
Dendritic Cells - immunology
Female
Gene expression
Genetic engineering
Gram-negative bacteria
Immunity, Innate
Immunogenicity
Infections
Inflammation
Laboratories
Membrane vesicle
Mice, Inbred C3H
Molecular weight
Peptides
Salmonella
Salmonella enterica typhimurium
Salmonella typhimurium
Salmonella typhimurium - immunology
Vaccine platform
Vaccines
title Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A14%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Altered%20host%20immune%20responses%20to%20membrane%20vesicles%20from%20Salmonella%20and%20Gram-negative%20pathogens&rft.jtitle=Vaccine&rft.au=Laughlin,%20Richard%20C&rft.date=2015-09-11&rft.volume=33&rft.issue=38&rft.spage=5012&rft.epage=5019&rft.pages=5012-5019&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2015.05.014&rft_dat=%3Cproquest_cross%3E3798264231%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c551t-4a017ae5be9e5dbef353d50a9f79c80868c84b95932ba0c63667205f9f82ce243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1709551211&rft_id=info:pmid/26001432&rfr_iscdi=true